A Kenyan family has spent more than Sh1 million in the search for a cure for Kala-azar, according to a report by Daily Nation published on Monday, August 31, 2026.
The report details the financial toll the disease has taken on the family as they sought treatment. Daily Nation describes the mounting expenses as a heartbreaking cost tied to the pursuit of a cure.
Kala-azar, also known as visceral leishmaniasis, is a parasitic disease that is fatal if left untreated. The Daily Nation report highlights the economic burden placed on patients and their families in Kenya, where accessing effective care can involve repeated hospital visits, travel, and prolonged treatment periods.
According to the outlet, the Sh1 million figure is not final, with the family's expenses continuing to rise as treatment remains ongoing. The report does not specify the family's location or the duration of their medical journey, but it underscores a broader challenge: the high out-of-pocket costs associated with a disease that primarily affects impoverished communities.
The Daily Nation story adds to growing concerns about neglected tropical diseases in East Africa, where patients often face both a health crisis and a financial one. The report suggests that even with medical advances, the cost of care can push families deeper into hardship.
What to watch next: whether Kenyan health authorities respond with measures to subsidize Kala-azar treatment or improve early diagnosis to reduce the financial strain on affected households.
